A carregar...
Alemtuzumab Use in Clinical Practice: Recommendations from European Multiple Sclerosis Experts
Alemtuzumab (Lemtrada™) is a humanized monoclonal antibody approved in more than 50 countries. Within the European Union, alemtuzumab is indicated for the treatment of adult patients with relapsing-remitting multiple sclerosis (RRMS) with active disease defined by clinical or imaging features; in th...
Na minha lista:
| Publicado no: | CNS Drugs |
|---|---|
| Main Authors: | , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Springer International Publishing
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5225231/ https://ncbi.nlm.nih.gov/pubmed/27882532 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40263-016-0394-8 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|